https://de.marketscreener.com/kurs/aktie/JW-CAYMAN-THERAPEUTICS-CO-119080133/news/JW-Therapeutics-gibt-IND-Zulassung-fur-die-klinische-Studie-mit-Relma-cel-bei-Patienten-mit-mittels-43464474/?utm_source=telegram&utm_medium=social&utm_campaign=share